General Information of Drug (ID: DM3XW3F)

Drug Name
KarXT
Indication
Disease Entry ICD 11 Status REF
Schizophrenia 6A20 Phase 3 [1]
Cross-matching ID
TTD ID
D0V9WX

References

1 ClinicalTrials.gov (NCT04820309) An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5). U.S. National Institutes of Health.